Foresite Capital Management IV, LLC - LYELL IMMUNOPHARMA INC ownership

LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 63 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.8%.

Quarter-by-quarter ownership
Foresite Capital Management IV, LLC ownership history of LYELL IMMUNOPHARMA INC
ValueSharesWeighting
Q3 2023$12,913,675
-58.1%
8,784,813
-9.4%
7.17%
-52.7%
Q2 2023$30,846,000
+30.7%
9,700,000
-3.0%
15.16%
+23.8%
Q1 2023$23,600,000
-32.0%
10,000,0000.0%12.24%
-17.4%
Q4 2022$34,700,000
-52.7%
10,000,0000.0%14.82%
-37.1%
Q3 2022$73,300,000
-15.4%
10,000,000
-24.7%
23.57%
+1.1%
Q2 2022$86,600,000
+29.1%
13,282,1810.0%23.32%
+24.3%
Q1 2022$67,075,000
-34.8%
13,282,1810.0%18.76%
-11.3%
Q4 2021$102,804,000
-47.7%
13,282,1810.0%21.15%
-26.9%
Q3 2021$196,576,000
-8.9%
13,282,1810.0%28.95%
-0.7%
Q2 2021$215,703,00013,282,18129.16%
Other shareholders
LYELL IMMUNOPHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 20,162,332$156,056,00045.49%
Foresite Capital Management IV, LLC 13,282,181$102,804,00021.15%
Apoletto Ltd 15,093,969$116,827,00014.55%
SB Management Ltd 3,500,000$27,090,0002.68%
HSG Holding Ltd 3,045,997$23,576,0002.11%
MIC Capital Management UK LLP 1,320,000$10,217,0001.95%
Alphabet Inc. 5,865,125$45,396,0001.10%
Board of Trustees of The Leland Stanford Junior University 1,647,882$12,754,0000.80%
Adero Partners, LLC 491,372$3,803,0000.62%
Ergoteles LLC 1,008,428$7,805,0000.30%
View complete list of LYELL IMMUNOPHARMA INC shareholders